Key Segmentation
By Treatment Type
-
Hormonal Therapies
-
Non-Hormonal Therapies
-
Dietary Supplements and Herbal Remedies
-
Cognitive Behavioral Therapy and Lifestyle Interventions
-
Others
By Route of Administration
-
Oral
-
Topical and Transdermal
-
Vaginal
-
Parenteral
-
Others
By Indication
-
Perimenopause
-
Menopause
-
Postmenopause
By Distribution Channel
-
Hospital Pharmacies
-
Drug Stores and Retail Pharmacies
-
Online Pharmacies
-
Others
Regional Coverage:
North America
-
United States
-
Canada
Europe
-
Germany
-
United Kingdom
-
France
-
Italy
-
Spain
-
Russia
-
Poland
-
Rest of Europe
Asia Pacific
-
China
-
India
-
Japan
-
South Korea
-
Australia
-
ASEAN Countries
-
Rest of Asia Pacific
Middle East & Africa
-
UAE
-
Saudi Arabia
-
Qatar
-
South Africa
-
Rest of Middle East & Africa
Latin America
-
Brazil
-
Argentina
-
Mexico
-
Colombia
-
Rest of Latin America
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
-
Detailed Volume Analysis
-
Criss-Cross segment analysis (e.g. Product X Application)
-
Competitive Product Benchmarking
-
Geographic Analysis
-
Additional countries in any of the regions
-
Customized Data Representation
-
Detailed analysis and profiling of additional market players
Frequently Asked Questions
Ans: The Menopause Treatment Market is expected to grow at a CAGR of 5.44% from 2026 to 2035.
Ans: The Menopause Treatment Market was valued at USD 18.81 billion in 2025.
Ans: The unprecedented demographic expansion of the global menopausal population toward 1.2 billion women by 2030, combined with the most active pharmaceutical innovation pipeline in the market's history including newly approved non-hormonal NK3 receptor antagonists, growing societal conversation reducing treatment-seeking stigma, and improving insurance coverage expanding access to evidence-based menopause therapies.
Ans: Dietary Supplements and Herbal Remedies dominated the market in 2025 with the largest revenue share, driven by the extensive global consumer market for phytoestrogen supplements, black cohosh, red clover, and targeted nutraceutical formulations accessed without prescription requirements through pharmacies, health food stores, and online channels by tens of millions of women globally.
Ans: North America dominated with the largest revenue share in 2025, led by the United States which accounted for over 75% of North American revenues through its advanced pharmaceutical market, the broadest FDA-approved treatment portfolio globally, and the most developed physician awareness and patient advocacy ecosystem for menopause management.
Get in Touch
